XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-based Compensation Expense Recognized

Stock‑based compensation expense recognized was as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

 

$

971

 

 

$

285

 

 

$

1,756

 

 

$

545

 

General and administrative

 

 

2,124

 

 

 

824

 

 

 

4,070

 

 

 

1,538

 

Total stock-based compensation expense

 

$

3,095

 

 

$

1,109

 

 

$

5,826

 

 

$

2,083

 

Weighted-Average Assumptions used in Estimating Fair Value of each Stock Options using Black-Scholes Option-Pricing Model

The fair value of each stock option was estimated using the Black‑Scholes option‑pricing model with the following weighted-average assumptions:

 

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

Risk-free interest rate

 

 

2.00

%

 

 

0.80

%

Expected volatility

 

 

92.78

%

 

 

89.34

%

Expected term (in years)

 

 

6.01

 

 

 

6.10

 

Expected dividend yield

 

 

 

 

 

 

Summary of Option Activity Changes in Shares Available for Grant under the 2020 Plan

Changes in shares available for grant under the 2020 Plan during the six months ended June 30, 2022 were as follows:

 

 

 

Shares
Available
for Grant

 

Shares available for grant at December 31, 2021

 

 

4,442,315

 

2020 Plan reserve increase on January 1, 2022

 

 

1,868,953

 

Options and restricted stock units granted

 

 

(1,998,047

)

Options and restricted stock units forfeited,
   cancelled, or expired

 

 

143,233

 

Shares available for grant at June 30, 2022

 

 

4,456,454

 

Summary of Option Activity under the 2020 Plan

A summary of stock option activity under the 2020 Plan for the six months ended June 30, 2022 was as follows:

 

 

 

Shares

 

 

Weighted-
Average
Exercise
price
per Share

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in
thousands)

 

Balance at December 31, 2021

 

 

2,270,896

 

 

$

12.76

 

 

7.22

 

 

$

8,306

 

Granted

 

 

1,985,797

 

 

 

10.43

 

 

 

 

 

 

 

Exercised

 

 

(288,457

)

 

 

1.02

 

 

 

 

 

 

 

Forfeited/expired

 

 

(129,233

)

 

 

17.26

 

 

 

 

 

 

 

Balance at June 30, 2022

 

 

3,839,003

 

 

$

12.28

 

 

 

8.82

 

 

$

793

 

Expected to vest

 

 

2,957,147

 

 

$

12.54

 

 

 

9.20

 

 

$

204

 

Options exercisable

 

 

881,856

 

 

$

11.42

 

 

 

7.57

 

 

$

589

 

Summary of Stock Options Outstanding and Exercisable under the 2020 Plan

Stock options outstanding and exercisable under the 2020 Plan consisted of the following at June 30, 2022:

 

 

 

 

 

Exercise Price ($)

 

Shares
Outstanding

 

 

Shares
Exercisable

 

0.16 to 1.35

 

 

399,762

 

 

 

279,963

 

8.93 to 19.94

 

 

3,061,320

 

 

 

499,390

 

20.55 to 29.41

 

 

377,921

 

 

 

102,503

 

Total

 

 

3,839,003

 

 

 

881,856

 

Restricted Stock Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Restricted Stock Activity

A summary of RSU activity for the six months ended June 30, 2022 is as follows:

 

 

 

Share
Equivalent

 

 

Weighted-
Average
Grant Date
Fair Value

 

Non-vested at December 31, 2021

 

 

361,500

 

 

$

15.32

 

Granted

 

 

12,250

 

 

 

10.54

 

Cancelled

 

 

(14,000

)

 

 

15.34

 

Vested

 

 

(119,911

)

 

 

15.15

 

Non-vested at June 30, 2022

 

 

239,839

 

 

$

15.15